Fibroblastic/Myofibroblastic Tumors

  • Piero PicciEmail author
  • Angelo Paolo Dei Tos
  • Marco Gambarotti
  • Alberto Righi


Fibroblastic/myofibroblastic sarcomas are mainly recognized and classified in the soft tissues while in the bone fewer entities were recognized.


Undifferentiated pleomorphic sarcoma Undifferentiated fibrosarcoma Infantile fibrosarcoma Dermatofibrosarcoma protuberans/fibrosarcoma Solitary fibrous tumor Myxofibrosarcoma Myofibroblastic sarcoma Low-grade fibromyxoid sarcoma (Evans’ tumor) Sclerosing epithelioid fibrosarcoma Myxoinflammatory fibroblastic sarcoma (Kindblom’s tumor) 

Selected Bibliography

  1. Alaggio R, Bisogno G, Rosato A, Ninfo V, Coffin CM. Undifferentiated sarcoma: does it exist? A clinicopathologic study of 7 pediatric cases and review of literature. Hum Pathol. 2009;40(11):1600–10, Review.CrossRefGoogle Scholar
  2. Al-Agha OM, Igbokwe AA. Malignant fibrous histiocytoma: between the past and the present. Arch Pathol Lab Med. 2008;132(6):1030–5, Review.PubMedGoogle Scholar
  3. Anders JO, Aurich M, Lang T, Wagner A. Solitary fibrous tumor in the thigh: review of the literature. J Cancer Res Clin Oncol. 2006;132(2):69–75, Review.CrossRefGoogle Scholar
  4. Antonescu CR, Baren A. Spectrum of low-grade fibrosarcomas: a comparative ultrastructural analysis of low-grade myxofibrosarcoma and fibromyxoid sarcoma. Ultrastruct Pathol. 2004;28(5–6):321–32.CrossRefGoogle Scholar
  5. Archontaki M, Korkolis DP, Arnogiannaki N, Konstantinidou C, Georgopoulos S, Dendrinos P, Zarkadas G, Kokkalis G. Dermatofibrosarcoma protuberans: a case series of 16 patients treated in a single institution with literature review. Anticancer Res. 2010;30(9):3775–9, Review.PubMedGoogle Scholar
  6. Arnaoutoglou C, Lykissas MG, Gelalis ID, Batistatou A, Goussia A, Doukas M, Xenakis TA. Low grade fibromyxoid sarcoma: a case report and review of the literature. J Orthop Surg Res. 2010;5:49.CrossRefPubMedPubMedCentralGoogle Scholar
  7. Bahrami A, Folpe AL. Adult-type fibrosarcoma: A reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period. Am J Surg Pathol. 2010;34(10):1504–13.CrossRefGoogle Scholar
  8. Bertoni F, Capanna R, Calderoni P, Patrizia B, Campanacci M. Primary central (medullary) fibrosarcoma of bone. Semin Diagn Pathol. 1984;1(3):185–98.PubMedGoogle Scholar
  9. Bielack SS, Schroeders A, Fuchs N, Bacci G, Bauer HC, Mapeli S, Tomeno B, Winkler K. Malignant fibrous histiocytoma of bone: a retrospective EMSOS study of 125 cases. European Musculo-Skeletal Oncology Society. Acta Orthop Scand. 1999;70(4):353–60.CrossRefGoogle Scholar
  10. Carlson JW, Fletcher CD. Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature. Histopathology. 2007;51(4):509–14, Review.CrossRefGoogle Scholar
  11. Chung EB, Enzinger FM. Infantile fibrosarcoma. Cancer. 1976;38(2):729–39.CrossRefGoogle Scholar
  12. Coffin CM, Sorensen PH. Infantile fibrosarcoma. In: World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press; 2013. p. 89–90.Google Scholar
  13. Coffin CM, Jaszcz W, O’Shea PA, Dehner LP. So-called congenital-infantile fibrosarcoma: does it exist and what is it? Pediatr Pathol. 1994;14(1):133–50.CrossRefGoogle Scholar
  14. Collini P, Sorensen PH, Patel S, Blay JY, Issels RD, Maki RG, Eriksson M, del Muro XG. Sarcomas with spindle cell morphology. Semin Oncol. 2009;36(4):324–37, Review.CrossRefGoogle Scholar
  15. Demicco EG, Park MS, Araujo DM, et al. Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Mod Pathol. 2012;25(9):1298–306.CrossRefGoogle Scholar
  16. Doyle LA, Wang WL, Dal Cin P, Lopez-Terrada D, Mertens F, Lazar AJ, Fletcher CD, Hornick JL. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement. Am J Surg Pathol. 2012;36:1444–51.CrossRefGoogle Scholar
  17. Erlandson RA, Antonescu CR, et al. Ultrastruct Pathol. 2004;28(5–6):283–9, Review. Erratum in: Ultrastruct Pathol. 2005;29(2):157.CrossRefGoogle Scholar
  18. Eyden B, Banerjee SS, Shenjere P, Fisher C. The myofibroblast and its tumours. J Clin Pathol. 2009;62(3):236–49, Review.CrossRefGoogle Scholar
  19. Fisher C. Myofibroblastic malignancies. Adv Anat Pathol. 2004;11(4):190–201, Review.CrossRefGoogle Scholar
  20. Fletcher CD. Myofibroblastic tumours: an update. Verh Dtsch Ges Pathol. 1998;82:75–82, Review.PubMedGoogle Scholar
  21. Fletcher CD, Dal Cin P, de Wever I, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, van den Berghe H, Vanni R, Willén H. Correlation between clinicopathological features and karyotype in spindle cell sarcomas. A report of 130 cases from the CHAMP study group. Am J Pathol. 1999;154(6):1841–7.CrossRefPubMedPubMedCentralGoogle Scholar
  22. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, editors. WHO classification of tumors of soft tissue and bone. 4th ed. Lyon: International Agency for Research on Cancer; 2013.Google Scholar
  23. Gooskens SL, Oranje AP, van Adrichem LN, de Waard-van der Spek FB, den Hollander JC, van de Ven CP, van den Heuvel-Eibrink MM. Imatinib mesylate for children with dermatofibrosarcoma protuberans (DFSP). Pediatr Blood Cancer. 2010;55(2):369–73, Review,Google Scholar
  24. Hattinger CM, Tarkkanen M, Benini S, Pasello M, Stoico G, Bacchini P, Knuutila S, Scotlandi K, Picci P, Serra M. Genetic analysis of fibrosarcoma of bone, a rare tumour entity closely related to osteosarcoma and malignant fibrous histiocytoma of bone. Eur J Cell Biol. 2004;83(9):483–91.CrossRefGoogle Scholar
  25. Hoekstra HJ, Ham SJ, van der Graaf WT, Kamps WA, Molenaar WM, Schraffordt Koops H. Malignant fibrous histiocytoma of bone: a clinicopathologic study of 81 patients. Cancer. 1998;82(5):993–4.CrossRefGoogle Scholar
  26. Kindblom LG, Mertens F, Coindre JM, Hornick JL, Meis JM. Sclerosing epithelioid fibrosarcoma. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press; 2013. p. 97–8.Google Scholar
  27. Koplas MC, Lefkowitz RA, Bauer TW, Joyce MJ, Ilaslan H, Landa J, Sundaram M. Imaging findings, prevalence and outcome of de novo and secondary malignant fibrous histiocytoma of bone. Skeletal Radiol. 2010;39(8):791–8.CrossRefGoogle Scholar
  28. Lombardi R, Jovine E, Zanini N, Salone MC, Gambarotti M, Righi A, Balladelli A, Colangeli M, Rocca M. A case of lung metastasis in myxoinflammatory fibroblastic sarcoma: analytical review of one hundred and thirty eight cases. Int Orthop. 2013;37(12):2429–36.CrossRefPubMedPubMedCentralGoogle Scholar
  29. Matushansky I, Charytonowicz E, Mills J, Siddiqi S, Hricik T, Cordon-Cardo C. MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st century. Expert Rev Anticancer Ther. 2009;9(8):1135–44, Review.CrossRefPubMedPubMedCentralGoogle Scholar
  30. McArthur G. Dermatofibrosarcoma protuberans: recent clinical progress. Ann Surg Oncol. 2007;14(10):2876–86, Review.CrossRefGoogle Scholar
  31. Meis JM, Kindblom LG, Mertens F. Myxoinflammtory fibroblastic sarcoma. In: World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press; 2013. p. 87–8.Google Scholar
  32. Meis-Kindblom JM, Enzinger FM. Sclerosing epithelioid fibrosarcoma. A variant of fibrosarcoma simulating carcinoma. Am J Surg Pathol. 1995;19:979–93.CrossRefGoogle Scholar
  33. Meis-Kindblom JM, Kindblom LG. Acral myxoinflammatory fibroblastic sarcoma: a low-grade tumor of the hands and feet. Am J Surg Pathol. 1998;22(8):911–24.CrossRefGoogle Scholar
  34. Meng GZ, Zhang HY, Zhang Z, Wei B, Bu H. Myofibroblastic sarcoma vs nodular fasciitis: a comparative study of chromosomal imbalances. Am J Clin Pathol. 2009;131(5):701–9.CrossRefGoogle Scholar
  35. Mertens F, Fletcher CD, Antonescu CR, Coindre JM, Colecchia M, Domanski HA, Downs-Kelly E, Fisher C, Goldblum JR, Guillou L, Reid R, Rosai J, Sciot R, Mandahl N, Panagopoulos I. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene. Lab Invest. 2005;85(3):408–15.CrossRefGoogle Scholar
  36. Michal M, Kazakov DV, Hadravský L, Kinkor Z, Kuroda N, Michal M. High-grade myxoinflammatory fibroblastic sarcoma: a report of 23 cases. Ann Diagn Pathol. 2015;19(3):157–63.CrossRefGoogle Scholar
  37. Michal M, Kazakov DV, Hadravský L, Agaimy A, Švajdler M, Kuroda N, Michal M. Pleomorphic hyalinizing angiectatic tumor revisited: all tumors manifest typical morphologic features of myxoinflammatory fibroblastic sarcoma, further suggesting 2 morphologic variants of a single entity. Ann Diagn Pathol. 2016;20:40–3.CrossRefGoogle Scholar
  38. Miura K, Han G, Sano M, Tsutsui Y. Regression of congenital fibrosarcoma to hemangiomatous remnant with histological and genetic findings. Pathol Int. 2002;52(9):612–8.CrossRefGoogle Scholar
  39. Mohajeri A, Tayebwa J, Collin A, Nilsson J, Magnusson L, von Steyern FV, Brosjö O, Domanski HA, Larsson O, Sciot R, Debiec-Rychter M, Hornick JL, Mandahl N, Nord KH, Mertens F. Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor. Genes Chromosomes Cancer. 2013 Oct;52(10):873–86.Google Scholar
  40. Monson E, Vancourt R, Dawson J. Myxoinflammatory fibroblastic sarcoma: a case report and review of the literature. J Foot Ankle Surg. 2010;49(1):86.e1–3, Review.CrossRefGoogle Scholar
  41. Nascimento AF, Raut CP. Diagnosis and management of pleomorphic sarcomas (so-called “MFH”) in adults. J Surg Oncol. 2008;97(4):330–9, Review.CrossRefGoogle Scholar
  42. Niini T, López-Guerrero JA, Ninomiya S, Guled M, Hattinger CM, Michelacci F, Böhling T, Llombart-Bosch A, Picci P, Serra M, Knuutila S. Frequent deletion of CDKN2A and recurrent coamplification of KIT, PDGFRA, and KDR in fibrosarcoma of bone--an array comparative genomic hybridization study. Genes Chromosomes Cancer. 2010;49(2):132–43.CrossRefGoogle Scholar
  43. Niini T, Lahti L, Michelacci F, Ninomiya S, Hattinger CM, Guled M, Böhling T, Picci P, Serra M, Knuutila S. Array comparative genomic hybridization reveals frequent alterations of G1/S checkpoint genes in undifferentiated pleomorphic sarcoma of bone. Genes Chromosomes Cancer. 2011;50:291–306.CrossRefGoogle Scholar
  44. Orbach D, Brennan B, De Paoli A, Gallego S, Mudry P, Francotte N, van Noesel M, Kelsey A, Alaggio R, Ranchère D, De Salvo GL, Casanova M, Bergeron C, Merks JH, Jenney M, Stevens MC, Bisogno G, Ferrari A. Conservative strategy in infantile fibrosarcoma is possible: the European Paediatric Soft Tissue Sarcoma Study Group experience. Eur J Cancer. 2016;57:1–9.CrossRefGoogle Scholar
  45. Palmerini E, Gambarotti M, Staals EL, Zanella L, Sieberova G, Longhi A, Cesari M, Bonarelli S, Picci P, Ruggieri P, Alberghini M, Ferrari S. Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberans. Clin Sarcoma Res. 2012;2(1):4. Scholar
  46. Papagelopoulos PJ, Galanis EC, Trantafyllidis P, Boscainos PJ, Sim FH, Unni KK. Clinicopathologic features, diagnosis, and treatment of fibrosarcoma of bone. Am J Orthop (Belle Mead NJ). 2002;31(5):253–7, Review.Google Scholar
  47. Park MS, Araujo DM. New insights into the hemangiopericytoma/solitary fibrous tumor spectrum of tumors. Curr Opin Oncol. 2009;21(4):327–31, Review.CrossRefGoogle Scholar
  48. Perez-Montiel MD, Plaza JA, Dominguez-Malagon H, Suster S. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue. Am J Dermatopathol. 2006;28(2):105–11.CrossRefGoogle Scholar
  49. Randall RL, Albritton KH, Ferney BJ, Layfield L. Malignant fibrous histiocytoma of soft tissue: an abandoned diagnosis. Am J Orthop (Belle Mead NJ). 2004;33(12):602–8, Review.Google Scholar
  50. Righi A, Gambarotti M, Manfrini M, Benini S, Gamberi G, Cocchi S, Casadei R, Picci P, Vanel D, Dei Tos AP. Sclerosing epithelioid fibrosarcoma of the thigh: report of two cases with synchronous bone metastases. Virchows Arch. 2015;467(3):339–44.CrossRefGoogle Scholar
  51. Sanerkin NG. Definitions of osteosarcoma, chondrosarcoma, and fibrosarcoma of bone. Cancer. 1980;46(1):178–85.CrossRefGoogle Scholar
  52. Sheng WQ, Hisaoka M, Okamoto S, Tanaka A, Meis-Kindblom JM, Kindblom LG, Ishida T, Nojima T, Hashimoto H. Congenital-infantile fibrosarcoma. A clinicopathologic study of 10 cases and molecular detection of the ETV6-NTRK3 fusion transcripts using paraffin-embedded tissues. Am J Clin Pathol. 2001;115(3):348–55.CrossRefGoogle Scholar
  53. Shidham VB, Ayala GE, Lahaniatis JE, Garcia FU. Low-grade fibromyxoid sarcoma: clinicopathologic case report with review of the literature. Am J Clin Oncol. 1999;22(2):150–5, Review.CrossRefGoogle Scholar
  54. Stadler FJ, Scott GA, Brown MD. Malignant fibrous tumors. Semin Cutan Med Surg. 1998;17(2):141–52.CrossRefGoogle Scholar
  55. Sundram UN. Review: dermatofibrosarcoma protuberans: histologic approach and updated treatment recommendations. Clin Adv Hematol Oncol. 2009;7(6):406–8, Review.PubMedGoogle Scholar
  56. Tarkkanen M, Larramendy ML, Böhling T, Serra M, Hattinger CM, Kivioja A, Elomaa I, Picci P, Knuutila S. Malignant fibrous histiocytoma of bone: analysis of genomic imbalances by comparative genomic hybridisation and C-MYC expression by immunohistochemistry. Eur J Cancer. 2006;42(8):1172–80.CrossRefGoogle Scholar
  57. Wan S, Ning L, Hong R, Wu W, Fan S, Tsuchiya H, Tomita K. Clinicopathological features of solitary fibrous tumours in the extremities: four case reports and a literature review. J Int Med Res. 2010;38(2):694–704, Review.CrossRefGoogle Scholar
  58. Wignall OJ, Moskovic EC, Thway K, Thomas JM. Solitary fibrous tumors of the soft tissues: review of the imaging and clinical features with histopathologic correlation. AJR Am J Roentgenol. 2010;195(1):W55–62, Review.CrossRefGoogle Scholar
  59. Wojcik JB, Bellizzi AM, Dal Cin P, Bredella MA, Fletcher CD, Hornicek FJ, Deshpande V, Hornick JL, Nielsen GP. Primary sclerosing epithelioid fibrosarcoma of bone: analysis of a series. Am J Surg Pathol. 2014;38:1538–44.CrossRefGoogle Scholar
  60. Wong SL. Diagnosis and management of desmoid tumors and fibrosarcoma. J Surg Oncol. 2008;97(6):554–8, Review.CrossRefGoogle Scholar
  61. Zreik RT, Carter JM, Sukov WR, Ahrens WA, Fritchie KJ, Montgomery EA, Weiss SW, Folpe AL. TGFBR3 and MGEA5 rearrangements are much more common in “hybrid” hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization study. Hum Pathol. 2016;53:14–24.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Piero Picci
    • 1
    • 2
    Email author
  • Angelo Paolo Dei Tos
    • 3
    • 4
  • Marco Gambarotti
    • 5
  • Alberto Righi
    • 5
  1. 1.Laboratory of Experimental OncologyIRCCS Istituto Ortopedico RizzoliBolognaItaly
  2. 2.I.S.G. Italian Sarcoma GroupBolognaItaly
  3. 3.Department of PathologyAzienda Ospedaliera di PadovaPaduaItaly
  4. 4.Department of MedicineUniversity of Padua School of MedicinePaduaItaly
  5. 5.Department of PathologyIRCCS Istituto Ortopedico RizzoliBolognaItaly

Personalised recommendations